The internationally recognized Radiation Oncology specialists at Miami Cancer Institute can sometimes treat prostate cancer with an extremely advanced technology called rectal spacer.
Rectal spacer technology moves the rectum away from the prostate, which reduces radiation exposure to the rectum, minimizing risk of treatment-induced gastrointestinal side effects for prostate cancer patients undergoing high-dose radiation.
Most patients can be candidates for rectal spacer technology, which the Cancer Institute’s experts often use for patients undergoing treatment that includes intensity modulated radiotherapy, stereotactic body radiotherapy, brachytherapy or proton therapy.
Internationally recognized radiation oncology expert Marcio Fagundes, M.D., is one of the first specialists anywhere to use rectal spacer technology for prostate cancer patients treated with proton therapy, introducing this innovative therapy to South Florida at the Cancer Institute.